Novavax NVAX
NASDAQ NVAX
$10.82 +0.02 (+0.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Novavax (NVAX) Operating Leases (2020 - 2025)

Updated

Novavax (NVAX) reported Operating Leases of $21.45 million for Q4 2025, down 72.0% from $76.68 million a year earlier.

Analysis

Novavax (NVAX) Operating Leases (2020 - 2025) Analysis & Trends

Dating back to Q4 2020, Novavax's Operating Leases record includes 6 quarters.

  • Operating Leases has a five-year compound annual growth rate of -15.6% (FY2020 to FY2025).
  • By year, Operating Leases came in at $76.68 million in FY2024 (-9.2%), $84.5 million in FY2023 (+3.9%), $81.32 million in FY2022 (+107.9%) and $39.12 million in FY2021 (-22.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Novavax 1.78 Bn -1.23 Bn 42.45 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 21.45 Mn
Dec 31, 2024 76.68 Mn
Dec 31, 2023 84.50 Mn
Dec 31, 2022 81.32 Mn
Dec 31, 2021 39.12 Mn
Dec 31, 2020 50.21 Mn
API Access

Novavax Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NVAX&period=max&api_key=YOUR_API_KEY